Table 5.
Year (analysis) | 0 (GZLM) | 1 (GZLM) | 2 (GZLM) | 0–1–2 (GEE) |
---|---|---|---|---|
Independent variables | P-valuea | P-value | P-value | P-value |
Intercept | <0.001 | <0.001 | <0.001 | <0.001 |
Patient group (1, 2 or 3) | <0.001 | 0.019 | 0.400 | 0.004 |
SF-36 Physical Component Summary at baseline | <0.001 | <0.001 | <0.001 | <0.001 |
Disease severity at baseline | 0.031 | 0.016 | <0.001 | <0.001 |
SF-36 Health Change at baseline | 0.009 | 0.763 | 0.098 | 0.196 |
Chronic Disease Score | 0.015 | 0.657 | 0.497 | 0.458 |
Gender | 0.031 | 0.818 | 0.468 | 0.209 |
Engagement in economic activity | 0.043 | 0.275 | 0.098 | 0.070 |
Living in former German Democratic Republic | 0.135 | 0.504 | 0.436 | 0.500 |
Disease duration | 0.665 | 0.501 | 0.839 | 0.960 |
Age | 0.842 | 0.946 | 0.888 | 0.866 |
Education | 0.869 | 0.615 | 0.141 | 0.364 |
a P-values are based on Wald chi-square statistics and indicate if the variable is a significant predictor in the model